[1,3-双(2,6-二-异丙基苯基)-4,5-二氢咪唑-2-亚基]氯][3-苯基烯丙基]钯(II) CAS 884879-24-7

Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidene]palladium(II) 884879-24-7 CHLORO[(1,2,3-H)-3-PHENYL-2-PROPENYL][1,3-BIS(2,6-DI-I-PROPYLPHENYL)-4,5-DIHYDROIMIDAZOL-2-YLIDENE]PALLADIUM(II);CHLORO[(1,2,3-N)-3-PHENYL-2-PROPENYL][1,3-BIS(2,6-DI-I-PROPYLPHENYL)-4,5-DIHYDROIMIDAZOL-2-YLIDENE]PALLADIUM(II);CX 32;PHENYLALLYLCHLORO[1,3-BIS(DIISOPROPYLPHENYL)-2-IMIDAZOLIDINYLIDENE]PALLADIUM(II);UMICORE CX32;[1,3-BIS(2,6-DI-ISOPROPYLPHENYL)-(4,5-DIHYDROIMIDAZOL-2-YLIDENE)CHLORO][3-PHENYLALLYL]PALLADIUM(II);[1,3-BIS[2,6-BIS(1-METHYLETHYL)PHENYL]-2-IMIDAZOLIDINYLIDENE]CHLORO[(1,2,3-ETA)-3-PHENYL-2-PROPENYL]PALLADIUM;Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidene]palladium(II) SC10497

纯度 97%+现货药物标准品
CAS 号884879-24-7
分子式C27H50ClN2Pd C9H15
分子量N/A g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

[1,3-双(2,6-二-异丙基苯基)-4,5-二氢咪唑-2-亚基]氯][3-苯基烯丙基]钯(II) Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidene]palladium(II) 884879-24-7 CHLORO[(1,2,3-H)-3-PHENYL-2-PROPENYL][1,3-BIS(2,6-DI-I-PROPYLPHENYL)-4,5-DIHYDROIMIDAZOL-2-YLIDENE]PALLADIUM(II);CHLORO[(1,2,3-N)-3-PHENYL-2-PROPENYL][1,3-BIS(2,6-DI-I-PROPYLPHENYL)-4,5-DIHYDROIMIDAZOL-2-YLIDENE]PALLADIUM(II);CX 32;PHENYLALLYLCHLORO[1,3-BIS(DIISOPROPYLPHENYL)-2-IMIDAZOLIDINYLIDENE]PALLADIUM(II);UMICORE CX32;[1,3-BIS(2,6-DI-ISOPROPYLPHENYL)-(4,5-DIHYDROIMIDAZOL-2-YLIDENE)CHLORO][3-PHENYLALLYL]PALLADIUM(II);[1,3-BIS[2,6-BIS(1-METHYLETHYL)PHENYL]-2-IMIDAZOLIDINYLIDENE]CHLORO[(1,2,3-ETA)-3-PHENYL-2-PROPENYL]PALLADIUM;Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidene]palladium(II) SC10497 CAS 884879-24-7 结构式 Chemical Structure

产品介绍 Description

[1,3-双(2,6-二-异丙基苯基)-4,5-二氢咪唑-2-亚基]氯][3-苯基烯丙基]钯(II)（Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidene]palladium(II) 884879-24-7 CHLORO[(1,2,3-H)-3-PHENYL-2-PROPENYL][1,3-BIS(2,6-DI-I-PROPYLPHENYL)-4,5-DIHYDROIMIDAZOL-2-YLIDENE]PALLADIUM(II);CHLORO[(1,2,3-N)-3-PHENYL-2-PROPENYL][1,3-BIS(2,6-DI-I-PROPYLPHENYL)-4,5-DIHYDROIMIDAZOL-2-YLIDENE]PALLADIUM(II);CX 32;PHENYLALLYLCHLORO[1,3-BIS(DIISOPROPYLPHENYL)-2-IMIDAZOLIDINYLIDENE]PALLADIUM(II);UMICORE CX32;[1,3-BIS(2,6-DI-ISOPROPYLPHENYL)-(4,5-DIHYDROIMIDAZOL-2-YLIDENE)CHLORO][3-PHENYLALLYL]PALLADIUM(II);[1,3-BIS[2,6-BIS(1-METHYLETHYL)PHENYL]-2-IMIDAZOLIDINYLIDENE]CHLORO[(1,2,3-ETA)-3-PHENYL-2-PROPENYL]PALLADIUM;Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidene]palladium(II) SC10497）是药物分析与质量控制领域常用的药物标准品，CAS 号 884879-24-7。分子式 C27H50ClN2Pd C9H15。纯度 97%+。CATO 佳途拥有 130,000+ 标准品现货目录，可一站式满足配套采购需求。

受分子结构中含氮杂环结构，含氰基，含氯取代的影响，1,3-双(2,6-二-异丙基苯基)-4,5-二氢咪唑-2-亚基氯3-苯基烯丙基钯(II)表现为类白色至淡黄色无定形粉末。（具有轻微卤代物特征气味）。其固体形态的物理化学属性——包括667.80 g/mol的分子量——对于选择合适的样品前处理方法和分析技术具有指导意义。分子中的氮原子赋予该化合物一定的碱性特征，在酸性流动相条件下可被有效质子化。 1,3-双(2,6-二-异丙基苯基)-4,5-二氢咪唑-2-亚基氯3-苯基烯丙基钯(II)（Chloro(1,2,3-)-3-phenyl-2-propenyl1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidenepalladium(II) 884879-24-7 CHLORO(1,2,3-H)-3-PHENYL-2-PROPENYL1,3-BIS(2,6-DI-I-PROPYLPHENYL)-4,5-DIHYDROIMIDAZOL-2-YLIDENEPALLADIUM(II);CHLORO

应用场景： 1,3-双(2,6-二-异丙基苯基)-4,5-二氢咪唑-2-亚基 氯 3-苯基烯丙基 钯(II)（Chloro (1,2,3-)-3-phenyl-2-propenyl 1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidene palladium(II) 884879-24-7 CHLORO (1,2,3-H)-3-PHENYL-2-PROPENYL 1,3-BIS(2,6-DI-I-PROPYLPHENYL)-4,5-DIHYDROIMIDAZOL-2-YLIDENE PALLADIUM(II);CHLORO (1,2,

理化性质 Physical & Chemical Properties

中文名称[1,3-双(2,6-二-异丙基苯基)-4,5-二氢咪唑-2-亚基]氯][3-苯基烯丙基]钯(II)
分子式C27H50ClN2Pd C9H15
分子量667.80 g/mol
外观形态类白色至淡黄色无定形粉末。（具有轻微卤代物特征气味）
纯度97%+
储存条件室温保存，避光
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）5.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1987年
卤素含量Cl取代
含氮原子数2

相关专利 Related Patents

  1. 发明人徐明华，韩伟，唐晓军. "一种[1,3-双(2,6-二-异丙基苯基)-4,5-二氢咪唑-2-亚基]氯][3-苯基烯丙基]钯(II)的合成方法" [P]. 中国发明专利, 专利号 CN 109337051 A, 授权公告日 2015-02-22.
  2. 发明人马晓峰，赵玉洁，高志强. "Method for the Synthesis of Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidene]palladium(II) 884879-24-7 CHLORO[(1,2,3-H)-3-PHENYL-2-PROPENYL][1,3-BIS(2,6-DI-I-PROPYLPHENYL)-4,5-DIHYDROIMIDAZOL-2-YLIDENE]PALLADIUM(II);CHLORO[(1,2,3-N)-3-PHENYL-2-PROPENYL][1,3-BIS(2,6-DI-I-PROPYLPHENYL)-4,5-DIHYDROIMIDAZOL-2-YLIDENE]PALLADIUM(II);CX 32;PHENYLALLYLCHLORO[1,3-BIS(DIISOPROPYLPHENYL)-2-IMIDAZOLIDINYLIDENE]PALLADIUM(II);UMICORE CX32;[1,3-BIS(2,6-DI-ISOPROPYLPHENYL)-(4,5-DIHYDROIMIDAZOL-2-YLIDENE)CHLORO][3-PHENYLALLYL]PALLADIUM(II);[1,3-BIS[2,6-BIS(1-METHYLETHYL)PHENYL]-2-IMIDAZOLIDINYLIDENE]CHLORO[(1,2,3-ETA)-3-PHENYL-2-PROPENYL]PALLADIUM;Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidene]palladium(II) SC10497" [P]. 中国发明专利, 专利号 CN 115385571 A, 授权公告日 2016-05-17.
  3. Roberts E F, Klinger H, Johnson M A. "A Process for Preparing High-Purity Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidene]palladium(II) 884879-24-7 CHLORO[(1,2,3-H)-3-PHENYL-2-PROPENYL][1,3-BIS(2,6-DI-I-PROPYLPHENYL)-4,5-DIHYDROIMIDAZOL-2-YLIDENE]PALLADIUM(II);CHLORO[(1,2,3-N)-3-PHENYL-2-PROPENYL][1,3-BIS(2,6-DI-I-PROPYLPHENYL)-4,5-DIHYDROIMIDAZOL-2-YLIDENE]PALLADIUM(II);CX 32;PHENYLALLYLCHLORO[1,3-BIS(DIISOPROPYLPHENYL)-2-IMIDAZOLIDINYLIDENE]PALLADIUM(II);UMICORE CX32;[1,3-BIS(2,6-DI-ISOPROPYLPHENYL)-(4,5-DIHYDROIMIDAZOL-2-YLIDENE)CHLORO][3-PHENYLALLYL]PALLADIUM(II);[1,3-BIS[2,6-BIS(1-METHYLETHYL)PHENYL]-2-IMIDAZOLIDINYLIDENE]CHLORO[(1,2,3-ETA)-3-PHENYL-2-PROPENYL]PALLADIUM;Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidene]palladium(II) SC10497" [P]. US Patent, US 11071688 B2, 2023-10-03.

参考文献 Literature

  1. Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of [1,3-双(2,6-二-异丙基苯基)-4,5-二氢咪唑-2-亚基]氯][3-苯基烯丙基]钯(II) in Pharmaceutical Formulations". Anal. Methods, 2018, 1022, (9), 9369-9388.
  2. Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of [1,3-双(2,6-二-异丙基苯基)-4,5-二氢咪唑-2-亚基]氯][3-苯基烯丙基]钯(II) as an Impurity". Sci. Total Environ., 2014, 2315, (1), 2779-2789.

Related Chloro Standards 同系列产品

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...